BindingDB logo
myBDB logout

null

SMILES: CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12

InChI Key: InChIKey=HOLMYYWTRUCOEO-KLPPZKSPSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50243906   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243906
PNG
(CHEMBL4063642)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.8,-11.92,;7.14,-12.68,;8.47,-11.91,;8.86,-10.41,;10.35,-10.81,;9.96,-12.3,;11.68,-10.03,;13.01,-10.8,;13.77,-12.13,;12.24,-12.12,;14.35,-10.03,;15.68,-10.8,;14.35,-8.49,;15.13,-7.16,;13.59,-7.16,;7.14,-14.22,;5.81,-15,;5.81,-16.54,;7.15,-17.31,;8.49,-16.53,;9.96,-17,;10.86,-15.75,;9.94,-14.5,;8.48,-14.99,)|
Show InChI InChI=1S/C15H22N6O2S/c1-20(15-13-5-6-16-14(13)17-9-18-15)12-7-10(8-12)19-24(22,23)21(2)11-3-4-11/h5-6,9-12,19H,3-4,7-8H2,1-2H3,(H,16,17,18)/t10-,12+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 17n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human JAK1 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM50243906
PNG
(CHEMBL4063642)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.8,-11.92,;7.14,-12.68,;8.47,-11.91,;8.86,-10.41,;10.35,-10.81,;9.96,-12.3,;11.68,-10.03,;13.01,-10.8,;13.77,-12.13,;12.24,-12.12,;14.35,-10.03,;15.68,-10.8,;14.35,-8.49,;15.13,-7.16,;13.59,-7.16,;7.14,-14.22,;5.81,-15,;5.81,-16.54,;7.15,-17.31,;8.49,-16.53,;9.96,-17,;10.86,-15.75,;9.94,-14.5,;8.48,-14.99,)|
Show InChI InChI=1S/C15H22N6O2S/c1-20(15-13-5-6-16-14(13)17-9-18-15)12-7-10(8-12)19-24(22,23)21(2)11-3-4-11/h5-6,9-12,19H,3-4,7-8H2,1-2H3,(H,16,17,18)/t10-,12+
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243906
PNG
(CHEMBL4063642)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.8,-11.92,;7.14,-12.68,;8.47,-11.91,;8.86,-10.41,;10.35,-10.81,;9.96,-12.3,;11.68,-10.03,;13.01,-10.8,;13.77,-12.13,;12.24,-12.12,;14.35,-10.03,;15.68,-10.8,;14.35,-8.49,;15.13,-7.16,;13.59,-7.16,;7.14,-14.22,;5.81,-15,;5.81,-16.54,;7.15,-17.31,;8.49,-16.53,;9.96,-17,;10.86,-15.75,;9.94,-14.5,;8.48,-14.99,)|
Show InChI InChI=1S/C15H22N6O2S/c1-20(15-13-5-6-16-14(13)17-9-18-15)12-7-10(8-12)19-24(22,23)21(2)11-3-4-11/h5-6,9-12,19H,3-4,7-8H2,1-2H3,(H,16,17,18)/t10-,12+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 328n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human JAK2 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243906
PNG
(CHEMBL4063642)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.8,-11.92,;7.14,-12.68,;8.47,-11.91,;8.86,-10.41,;10.35,-10.81,;9.96,-12.3,;11.68,-10.03,;13.01,-10.8,;13.77,-12.13,;12.24,-12.12,;14.35,-10.03,;15.68,-10.8,;14.35,-8.49,;15.13,-7.16,;13.59,-7.16,;7.14,-14.22,;5.81,-15,;5.81,-16.54,;7.15,-17.31,;8.49,-16.53,;9.96,-17,;10.86,-15.75,;9.94,-14.5,;8.48,-14.99,)|
Show InChI InChI=1S/C15H22N6O2S/c1-20(15-13-5-6-16-14(13)17-9-18-15)12-7-10(8-12)19-24(22,23)21(2)11-3-4-11/h5-6,9-12,19H,3-4,7-8H2,1-2H3,(H,16,17,18)/t10-,12+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.67E+3n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Compound was evaluated for the binding affinity to Endothelin A receptor in the rat atrium


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2/Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243906
PNG
(CHEMBL4063642)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(=O)(=O)N(C)C1CC1)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(5.8,-11.92,;7.14,-12.68,;8.47,-11.91,;8.86,-10.41,;10.35,-10.81,;9.96,-12.3,;11.68,-10.03,;13.01,-10.8,;13.77,-12.13,;12.24,-12.12,;14.35,-10.03,;15.68,-10.8,;14.35,-8.49,;15.13,-7.16,;13.59,-7.16,;7.14,-14.22,;5.81,-15,;5.81,-16.54,;7.15,-17.31,;8.49,-16.53,;9.96,-17,;10.86,-15.75,;9.94,-14.5,;8.48,-14.99,)|
Show InChI InChI=1S/C15H22N6O2S/c1-20(15-13-5-6-16-14(13)17-9-18-15)12-7-10(8-12)19-24(22,23)21(2)11-3-4-11/h5-6,9-12,19H,3-4,7-8H2,1-2H3,(H,16,17,18)/t10-,12+
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 186n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFNalpha induced STAT3 phosphorylation preincubated for 45 mins followed by IFN...


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair